Halia Therapeutics, Inc. announced it raised $5 Million in an initial filing from an offering of $5 Million

Company

Location

About

Halia is a clinical-stage biopharmaceutical company discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.